WO2003000733A3 - Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis - Google Patents
Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis Download PDFInfo
- Publication number
- WO2003000733A3 WO2003000733A3 PCT/EP2002/006767 EP0206767W WO03000733A3 WO 2003000733 A3 WO2003000733 A3 WO 2003000733A3 EP 0206767 W EP0206767 W EP 0206767W WO 03000733 A3 WO03000733 A3 WO 03000733A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- glycopeptides
- multiple sclerosis
- diagnosis
- preparation
- therapeutic treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
- C07K17/08—Peptides being immobilised on, or in, an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0400262A HUP0400262A3 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the treatment of multiple sclerosis |
IL15947902A IL159479A0 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
DE60226324T DE60226324T2 (en) | 2001-06-22 | 2002-06-19 | GLYCOPEPTIDES, THEIR PREPARATION AND USE IN THE DIAGNOSIS OR TREATMENT OF MULTIPLE SCLEROSIS |
US10/482,044 US7037893B2 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
AU2002316989A AU2002316989B2 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
PL368158A PL207174B1 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
DK02745396T DK1406927T3 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, Preparation and Use thereof for Diagnosis or Therapeutic Treatment of Disseminated Sclerosis |
EP02745396A EP1406927B1 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
CA2451347A CA2451347C (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
IL159479A IL159479A (en) | 2001-06-22 | 2003-12-21 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001FI000114A ITFI20010114A1 (en) | 2001-06-22 | 2001-06-22 | GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS |
ITFI2001A000114 | 2001-06-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003000733A2 WO2003000733A2 (en) | 2003-01-03 |
WO2003000733A3 true WO2003000733A3 (en) | 2003-11-13 |
Family
ID=11442221
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2002/006767 WO2003000733A2 (en) | 2001-06-22 | 2002-06-19 | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis |
Country Status (15)
Country | Link |
---|---|
US (1) | US7037893B2 (en) |
EP (1) | EP1406927B1 (en) |
AT (1) | ATE393785T1 (en) |
AU (1) | AU2002316989B2 (en) |
CA (1) | CA2451347C (en) |
CZ (1) | CZ2004122A3 (en) |
DE (1) | DE60226324T2 (en) |
DK (1) | DK1406927T3 (en) |
ES (1) | ES2305258T3 (en) |
HU (1) | HUP0400262A3 (en) |
IL (2) | IL159479A0 (en) |
IT (1) | ITFI20010114A1 (en) |
PL (1) | PL207174B1 (en) |
PT (1) | PT1406927E (en) |
WO (1) | WO2003000733A2 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITFI20010114A1 (en) | 2001-06-22 | 2002-12-22 | Univ Firenze | GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS |
ITFI20010144A1 (en) * | 2001-07-25 | 2003-01-25 | Univ Firenze | COLUMNS FOR IMMUNO ABSORPTION FOR SUBTRACTION OF ANTIBODIES FROM BLOOD WITH SELECTIVE PLASMAFILTRATION TECHNIQUES |
MXPA05001270A (en) | 2002-08-02 | 2005-08-03 | Glycominds Ltd | Method for diagnosing multiple sclerosis. |
US8216791B2 (en) | 2005-01-31 | 2012-07-10 | Glycominds Ltd. | Method for diagnosing multiple sclerosis |
US7572592B2 (en) | 2005-01-31 | 2009-08-11 | Glycominds Ltd | Method for diagnosing multiple sclerosis |
WO2008127642A1 (en) * | 2007-04-11 | 2008-10-23 | Enteron Limited Partnership | Myelin specific ige unencumbered by corresponding blocking antibodies as a causative factor in multiple sclerosis |
CN101680883A (en) * | 2007-04-12 | 2010-03-24 | 艾匹托普国际股份有限公司 | Biomarkers for multiple sclerosis |
ATE514711T1 (en) | 2007-10-16 | 2011-07-15 | Toscana Biomarkers S R L | GALACTOSYLATED PEPTIDES, THEIR PREPARATION AND USE FOR DIAGNOSING AUTOIMMUNE DISEASES |
US20100203569A1 (en) | 2009-02-12 | 2010-08-12 | Glycominks LTD | Method for Evaluating Risk in Multiple Sclerosis |
ITFI20120164A1 (en) | 2012-06-05 | 2013-12-06 | Azienda Ospedaliera Universitaria S Enese 50 | NEW GLYCOSYLATED PEPTIDES. |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997035879A1 (en) * | 1996-03-28 | 1997-10-02 | Immulogic Pharmaceutical Corporation | Myelin oligodendrocyte glycoprotein peptides and uses thereof |
WO1999057241A2 (en) * | 1998-05-05 | 1999-11-11 | Corixa Corporation | Myelin basic protein peptides and uses thereof |
WO2000012126A1 (en) * | 1998-08-26 | 2000-03-09 | The Regents Of The University Of California | Autoantibody inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITFI20010114A1 (en) | 2001-06-22 | 2002-12-22 | Univ Firenze | GLYCOPEPTIDES, THEIR PREPARATION AND THEIR USE IN THE DIAGNOSIS OR THERAPEUTIC TREATMENT OF MULTIPLE SCLEROSIS |
ITRM20010408A1 (en) * | 2001-07-10 | 2003-01-10 | Univ Napoli Federico Ii | CYTOTOXIC HUMAN MINI-ANTIBODY FOR CANCER CELLS THAT EXPRESS THE ERBB2 RECEPTOR. |
-
2001
- 2001-06-22 IT IT2001FI000114A patent/ITFI20010114A1/en unknown
-
2002
- 2002-06-19 EP EP02745396A patent/EP1406927B1/en not_active Expired - Lifetime
- 2002-06-19 CA CA2451347A patent/CA2451347C/en not_active Expired - Fee Related
- 2002-06-19 DK DK02745396T patent/DK1406927T3/en active
- 2002-06-19 PL PL368158A patent/PL207174B1/en not_active IP Right Cessation
- 2002-06-19 US US10/482,044 patent/US7037893B2/en not_active Expired - Fee Related
- 2002-06-19 AU AU2002316989A patent/AU2002316989B2/en not_active Ceased
- 2002-06-19 CZ CZ2004122A patent/CZ2004122A3/en unknown
- 2002-06-19 WO PCT/EP2002/006767 patent/WO2003000733A2/en active IP Right Grant
- 2002-06-19 HU HU0400262A patent/HUP0400262A3/en unknown
- 2002-06-19 PT PT02745396T patent/PT1406927E/en unknown
- 2002-06-19 ES ES02745396T patent/ES2305258T3/en not_active Expired - Lifetime
- 2002-06-19 IL IL15947902A patent/IL159479A0/en unknown
- 2002-06-19 DE DE60226324T patent/DE60226324T2/en not_active Expired - Lifetime
- 2002-06-19 AT AT02745396T patent/ATE393785T1/en active
-
2003
- 2003-12-21 IL IL159479A patent/IL159479A/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997035879A1 (en) * | 1996-03-28 | 1997-10-02 | Immulogic Pharmaceutical Corporation | Myelin oligodendrocyte glycoprotein peptides and uses thereof |
WO1999057241A2 (en) * | 1998-05-05 | 1999-11-11 | Corixa Corporation | Myelin basic protein peptides and uses thereof |
WO2000012126A1 (en) * | 1998-08-26 | 2000-03-09 | The Regents Of The University Of California | Autoantibody inhibitors |
Non-Patent Citations (1)
Title |
---|
MAZZUCCO S ET AL: "A Synthetic Glycopeptide of Human Myelin Oligodendrocyte Glycoprotein To Detect Antibody Responses in Multiple Sclerosis and Other Neurological Diseases", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 9, no. 2, 18 January 1999 (1999-01-18), pages 167 - 172, XP004152593, ISSN: 0960-894X * |
Also Published As
Publication number | Publication date |
---|---|
WO2003000733A2 (en) | 2003-01-03 |
IL159479A0 (en) | 2004-06-01 |
CZ2004122A3 (en) | 2004-07-14 |
IL159479A (en) | 2010-12-30 |
PT1406927E (en) | 2008-07-31 |
DE60226324D1 (en) | 2008-06-12 |
EP1406927A2 (en) | 2004-04-14 |
PL368158A1 (en) | 2005-03-21 |
HUP0400262A3 (en) | 2008-05-28 |
ITFI20010114A1 (en) | 2002-12-22 |
ATE393785T1 (en) | 2008-05-15 |
PL207174B1 (en) | 2010-11-30 |
AU2002316989B2 (en) | 2006-10-26 |
ES2305258T3 (en) | 2008-11-01 |
DE60226324T2 (en) | 2009-07-09 |
HUP0400262A2 (en) | 2004-08-30 |
US20040235713A1 (en) | 2004-11-25 |
CA2451347A1 (en) | 2003-01-03 |
DK1406927T3 (en) | 2008-08-18 |
US7037893B2 (en) | 2006-05-02 |
EP1406927B1 (en) | 2008-04-30 |
CA2451347C (en) | 2011-07-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003039462A3 (en) | B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies | |
WO2005027733A3 (en) | Biological markers for diagnosing multiple sclerosis | |
MXPA02011656A (en) | Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods. | |
WO2003066661A3 (en) | Human dr4 antibodies and uses thereof | |
WO1999051748A3 (en) | Fusion proteins of mycobacterium tuberculosis antigens and their uses | |
SI1757606T1 (en) | Xanthinderivatives for use as medical agents and the preparation thereof | |
ZA200409492B (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
MXPA02003027A (en) | Method for providing clinical diagnostic services. | |
AU2002308348A1 (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours | |
MXPA03008739A (en) | Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours. | |
AU2001275820A1 (en) | Diagnostic agents for the prenatal diagnosis of preterm delivery, fetal infection, and fetal damage, and diagnostic kit containing the same | |
AU2003290605A1 (en) | Compositions and methods for the diagnosis and treatment of sepsis | |
WO2003000733A3 (en) | Glycopeptides, their preparation and use in the diagnosis or therapeutic treatment of multiple sclerosis | |
AU2002317172A1 (en) | Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases | |
WO2003084384A3 (en) | Diagnosis of flavivirus infection | |
WO2003057146A3 (en) | Novel compositions and methods for cancer | |
AU2002219137A1 (en) | Diagnosis kit, dna chip, and methods for diagnosing or supervising the treatment of testicular cancer | |
WO2004047757A3 (en) | Diagnosing and treating hematopoietic cancers | |
IL173546A0 (en) | Pentafluorosulfanylphenyl-substituted benzoylguanidines, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them | |
AU4204700A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
WO2002024738A1 (en) | β-CATENIN NUCLEAR LOCALIZED PROTEIN | |
EP2322559A3 (en) | Neoplasm specific antibodies and uses thereof | |
AU2002306600A1 (en) | Sperm protein 17 for the diagnosis and treatment of cancer | |
AU2002210438A1 (en) | Diagnosis of diseases which are associated with cd24 | |
AU1820499A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG US |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 159479 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10482044 Country of ref document: US Ref document number: 2451347 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002745396 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002316989 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2004-122 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 2002745396 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2004-122 Country of ref document: CZ |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002745396 Country of ref document: EP |